G
Giancarlo Viberti
Researcher at King's College London
Publications - 236
Citations - 19773
Giancarlo Viberti is an academic researcher from King's College London. The author has contributed to research in topics: Diabetes mellitus & Microalbuminuria. The author has an hindex of 69, co-authored 235 publications receiving 18659 citations. Previous affiliations of Giancarlo Viberti include University of Cambridge & Guy's Hospital.
Papers
More filters
Journal ArticleDOI
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.
Steven E. Kahn,Steven M. Haffner,Heise Ma,William H. Herman,Rury R. Holman,Nigel P. Jones,Barbara G. Kravitz,John M. Lachin,O'Neill Mc,Bernard Zinman,Giancarlo Viberti +10 more
TL;DR: The potential risks and benefits, the profile of adverse events, and the costs of these three drugs should all be considered to help inform the choice of pharmacotherapy for patients with type 2 diabetes.
Journal ArticleDOI
Microalbuminuria Reduction With Valsartan in Patients With Type 2 Diabetes Mellitus A Blood Pressure–Independent Effect
TL;DR: For the same level of attained BP and the same degree of BP reduction, valsartan lowered UAER more effectively than amlodipine in patients with type 2 diabetes and microalbuminuria, including the subgroup with baseline normotension, which indicates a BP-independent antiproteinuric effect of vALSartan.
Journal ArticleDOI
Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
Hermann Haller,Sadayoshi Ito,Joseph L. Izzo,Andrzej Januszewicz,Shigehiro Katayama,Jan Menne,Albert Mimran,Ton J. Rabelink,Eberhard Ritz,Luis M. Ruilope,Lars Christian Rump,Giancarlo Viberti +11 more
TL;DR: Olmesartan was associated with a delayed onset of microalbuminuria, even though blood-pressure control in both groups was excellent according to current standards.
Journal ArticleDOI
Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria
TL;DR: Captopril therapy significantly impeded progression to clinical proteinuria and prevented the increase in albumin excretion rate in nonhypertensive patients with insulin-dependent diabetes mellitus and persistent microalbuminuria.
Journal ArticleDOI
Prevention of diabetic renal disease with special reference to microalbuminuria
Carl Erik Mogensen,William F. Keane,Peter H. Bennett,George Jerums,Hans-Henrik Parving,Philippe Passa,Michael W. Steffes,Gary E. Striker,Giancarlo Viberti +8 more
TL;DR: In this paper, the authors developed a strategy to develop programmes for all patients with diabetes, focused on early detection of renal disease followed by intervention, to prevent the development of end-stage renal failure.